(silver · DailyMed)
BEDIZIN CREAM
SILVER SULFACLIAZINE
What it does
Silver is used in various medical applications, particularly for its antibacterial properties.
Commonly used for: wound healing, burn treatment, infection prevention
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Food and Drugs Authority · fetched 2026-04-18 08:33:06 · updated 2026-09-18 04:00:13
About silver
Silver is used in various medical applications, particularly for its antibacterial properties.
What it treats
- wound healing
- burn treatment
- infection prevention
How it works
Silver helps kill bacteria and reduce the risk of infection in wounds and burns.
Who it's for
It is suitable for individuals with wounds or burns that need to be protected from infection.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About sulfacliazine
Sulfacliazine is an antibiotic that helps treat infections caused by bacteria.
What it treats
- bacterial infections
- infectious diseases
How it works
It works by stopping the growth of bacteria in the body.
Who it's for
It is used for people who have certain types of bacterial infections.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: silver
BNF-referencedSilver is a metallic element with antimicrobial properties, primarily used in various medical and dental applications due to its ability to inhibit a wide range of microorganisms. It is commonly employed in wound care, as well as in dental treatments to prevent and manage caries. Silver ions exert their effects by disrupting cell membranes of bacteria, fungi, and protozoa, leading to cellular damage and death.
Indications
- Management of wounds
- Burn treatment
- Dental caries prevention
- Topical antiseptic
- Infection control in medical devices
Dosage
Children: Refer to BNF for Children for age-appropriate dosing recommendations.
Adults: Refer to BNF for specific dosing guidelines depending on the clinical context and formulation used.
Mechanism of action
Silver ions precipitate with chloride or phosphate anions and bind to proteins, leading to antibacterial effects by disrupting cell membranes. They can bind to peptidoglycans in bacterial cell walls, causing loss of structural integrity and function. Silver also binds to and oxidizes sulphydryl groups in enzymes, inhibiting metabolic processes. Additionally, silver ions may attach to bacterial DNA, inhibiting replication, and silver nanoparticles can generate reactive oxygen species, causing oxidative stress.
Pharmacodynamics
Silver exhibits broad-spectrum antimicrobial activity, effective against both Gram-positive and Gram-negative bacteria, including _Streptococcus mutans_, _Staphylococcus aureus_, and _Escherichia coli_. It has shown dose-dependent effects against methicillin-resistant Staphylococcus aureus (MRSA). Furthermore, silver compounds have demonstrated anti-inflammatory properties in models of skin inflammation and ulcerative colitis, suppressing pro-inflammatory cytokines and matrix metalloproteinases.
Pharmacokinetics
Silver does not have a well-defined pharmacokinetic profile due to its nature as a metal; however, it is known to bind extensively to proteins and tissues. Chronic exposure to silver can lead to accumulation and potential toxicity. The absorption and distribution of silver ions can vary based on the form of silver administered, with nanoparticles showing different properties compared to ionic silver.
Pregnancy
Safety during pregnancy has not been established. Use only if clearly needed.
Breast-feeding
Caution is advised as it is not known whether silver is excreted in human milk.
Storage
Store in a well-closed container, protected from light, at room temperature.
Formulations
- Silver nitrate
- Nanocrystalline silver
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: sulfacliazine
Sulfadiazine is a sulfonamide antibiotic that inhibits bacterial growth by interfering with the synthesis of folic acid. It is used primarily in the treatment of various bacterial infections, including those caused by specific strains of bacteria, and is notably used in combination therapies for conditions such as toxoplasmosis.
Indications
- Bacterial infections
- Toxoplasmosis
- Urinary tract infections
- Respiratory tract infections
- Burn infections
Dosage
Children: Refer to clinical guidelines or specific BNF resources for paediatric dosing.
Adults: Refer to clinical guidelines or specific BNF resources for adult dosing.
Mechanism of action
Sulfadiazine acts as a competitive inhibitor of para-aminobenzoic acid (PABA), a substrate necessary for the synthesis of folic acid in bacteria. By inhibiting the enzyme dihydropteroate synthase, it prevents the production of dihydropteroic acid, an intermediate in folate biosynthesis. This ultimately leads to bacterial cell death due to the depletion of essential folate required for nucleic acid synthesis.
Pharmacodynamics
Sulfadiazine exhibits bacteriostatic activity, meaning that it inhibits the growth and reproduction of bacteria rather than killing them directly. Its effectiveness is influenced by the presence of other antimicrobial agents, particularly in combination therapies, which can enhance its efficacy against resistant strains.
Pharmacokinetics
Sulfadiazine is well absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 2 to 6 hours after oral administration. It is widely distributed throughout body tissues and fluids, including the central nervous system and synovial fluid. The drug is metabolized in the liver primarily via acetylation and is excreted predominantly in the urine as unchanged drug and metabolites. The half-life of sulfadiazine varies based on individual patient factors, but it is generally around 8 to 12 hours.
Contra-indications
- Hypersensitivity to sulfonamides
- Severe renal impairment
- Porphyria
- Pregnancy near term due to risk of kernicterus
Adverse effects
- Allergic reactions including rash and fever
- Gastrointestinal disturbances such as nausea and vomiting
- Hematological effects including agranulocytosis and thrombocytopenia
- Renal toxicity including crystalluria
- Photosensitivity
- Liver toxicity
Interactions
- May enhance the effect of anticoagulants
- Can interact with methotrexate, increasing toxicity
- May reduce the effectiveness of oral contraceptives
- Concurrent use with other nephrotoxic drugs may increase risk of renal damage
Precautions
- Monitor renal function in patients receiving prolonged therapy
- Use with caution in patients with G6PD deficiency
- Assess for potential drug interactions before initiation
- Consider alternative therapies in patients with known sulfonamide allergies
Pregnancy
Use during pregnancy is not recommended, particularly near term, due to the risk of kernicterus in the newborn.
Breast-feeding
Sulfadiazine is excreted in breast milk, caution is advised when administering to breastfeeding mothers.
Storage
Store in a cool, dry place away from light. Keep out of reach of children.
Formulations
- Tablets
- Injectable forms
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: silver
PubChem CID 23954Molecular formula: Ag
Mechanism of action
The majority of released silver ions precipitate with chloride or phosphate anions or bind to albumins, macroglobulins, or tissue debris. While bound silver ions do not exert antibacterial actions, they may potentially play a role in silver toxicity in case of chronic exposure. Silver ions mediate antibacterial effects via disrupting the bacterial, fungal, and protozoal cell membranes; they bind to disulphide in membrane proteins, readily allowing penetration through the membranes and intracellular absorption via pinocytosis. They may also bind to negatively-charged peptidoglycans in the cell wall via electrostatic interactions, leading to disruption of membrane transport function and loss of structural integrity. Silver ions also bind to and oxidize sulphydryl groups (SH) in bacterial cytoplasmic enzymes to aberrate their function in metabolic processes. Silver nanoparticles may cause an increase in reactive oxygen species (ROS) inside the microbial cells leading to metal-induced oxidative stress and cell damage. They also modulate cellular signal system via inhibition of phosphorylation of essential bacterial proteins to eventually cause cell death. It is also reported that silver ions also attach to guanine in bacterial DNA, which inhibits DNA replication. While it is not fully understood, the mode of action of silver compounds in preventing and arresting dental caries is thought to involve inhibition of the demineralization process in addition to cytoplasmic and membrane function perturbation mentioned above. Silver compounds may directly interact with hydroxyapatite, a major tooth component. Light catalyzes the reduction of silver salts deposited in skin to metallic silver & it /is/ subsequently oxidized to silver sulfide; it is the deposition of the latter compound which accounts for the gray discoloration pathognomonic of argyria. /Silver and compounds/ Silver nanoparticles (nano-Ag) are potent and broad-spectrum antimicrobial agents. In this study, spherical nano-Ag (average diameter = 9.3 nm) particles were synthesized using a borohydride reduction method and the mode of their antibacterial action against E. coli was investigated by proteomic approaches (2-DE and MS identification), conducted in parallel to analyses involving solutions of Ag(+) ions. The proteomic data revealed that a short exposure of E. coli cells to antibacterial concentrations of nano-Ag resulted in an accumulation of envelope protein precursors, indicative of the dissipation of proton motive force. Consistent with these proteomic findings, nano-Ag were shown to destabilize the outer membrane, collapse the plasma membrane potential and deplete the levels of intracellular ATP. The mode of action of nano-Ag was also found to be similar to that of Ag(+) ions ... however, the effective concentrations of nano-Ag and Ag(+) ions were at nanomolar and micromolar levels, respectively. Nano-Ag appear to be an efficient physicochemical system conferring antimicrobial silver activities.
Pharmacodynamics
Silver exhibits a broad-spectrum antimicrobial activity. Silver ions were shown to mediate an effective antibacterial action against _Streptococcus mutans_, one of major bacteria present in the human oral cavity and one of etiological microorganism of dental caries. A study reported a dose-dependent antimicrobial activity of silver nanoparticles against MRSA and non-MRSA bacteria. Silver nanoparticles were also shown to mediate antibacterial activity against Gram-positive _S. aureus_ and Gram-negative _E. coli_ by inhibiting the growth. In experimental dinitrochlorobenzene-induced inflammatory models in porcine or murine skin, topical application of silver nitrate and nanocrystalline silver were shown to exert anti-inflammatory effects associated with lymphocyte apoptosis, decreased expression of pro-inflammatory cytokines, and reduced gelatinase activity. In a rat model of ulcerative colitis, orally or intracolonically administered nanocrystalline silver were shown to suppress matrix metalloproteinase (MMP-9), tumour necrosis factor (TNF), and interleukin-β (IL-β) and IL-12.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: Silvernitrate
PubChem CID 24470Molecular formula: AgNO3
Mechanism of action
To elucidate the possible mechanism of initiation of lipid peroxidation in silver nitrate treated erythrocytes, the effect of AgNO3 on Hb catalyzed peroxidation of phospholipid liposomes was studied. Ag+ significantly increases the rate of Hb-catalyzed peroxidation. The inhibition of this effect by superoxide dismutase and catalase suggests that superoxide radical and H2O2 are involved. It was demonstrated also that Ag+ potentiates the Hb autoxidation and increases the binding of Hb to the erythrocyte membrane. Silver nitrate exhibits antiseptic, germicidal, astringent, and caustic or escharotic activity. These effects may result from silver ions readily combining with sulfhydryl, carboxyl, phosphate, amino, and other biologically important chemical groups. When silver ions interact with proteins, physical properties of the protein are usually altered; the protein may be denatured and precipitation usually occurs. Silver ions act on the surface of bacteria causing substantial changes in the cell wall and membrane. The germicidal activity of silver nitrate may be attributed to precipitation of bacterial proteins by liberated silver ions.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- BURNAZINE CREAM · Laboratory & Allied
- BURNFIX CREAM · Signature Healthcare
- BURNIMED CREAM · Medivet Products
- BURNOX CREAM · Beta Healthcare
- BURNSIL CREAM · Madawa Pharmaceuticals
- DERMAZINE CREAM · Dawa
- BACTRAZINE 0.1% CREAM
- BURN HEAL 1%W/W CREAM
- BURNCURE 1%W/W CREAM
- BURNOX COMBINATION PRODUCT CREAM
- DERMAZINE 1% CREAM
- DERMAZINE_PLUS COMBINATION PRODUCT CREAM
- Argisept · Centaur Pharmaceuticals
- Burn Cream · Prince Pharmaceuticals
- Burnox · Shelys Pharmaceuticals
- Dermogard · Indi Pharma
- HYPEX · Imaec
- NEMSCALD · Nem Laboratories
- Argisept cream · Centaur Pharmaceuticals
- Burnazine (Silver Sulphadiazine 1%) Cream · Laboratory & Allied
- Burnazine cream · Laboratory And Allied
- Burnox cream · Shelys Pharmaceuticals
- Dermazine Cream · Dawa
- Flazine cream · Gopaldas Visram